You are here: News & Resources > Market News > Director Deals - GlaxoSmithKline PLC (GSK)

Director Deals - GlaxoSmithKline PLC (GSK)

Andrew Witty, Chief Executive Officer, bought 10 shares in the company on the 9th December 2010 at a price of 1249.00p. The Director now holds 296,446 shares.

NOTE: co's Share reward plan. Also awarded 10 matching shares.

Story provided by StockMarketWire.com

10/12/2010

When investing in stockmarkets there is the risk of loss to investors' capital and income. Click on "Risk Warning" below for further details.

Hargreave Hale Limited ("Hargreave Hale") is authorised and regulated by the Financial Services Authority (No. 209741).
and is a member of the London Stock Exchange, the Plus Market and APCIMS. The company is incorporated in England and Wales, Company No. 3146580.
The registered office is at 9-11 Neptune Court, Hallam Way, Blackpool, FY4 5LZ.